Transcending cloud finops to get value in the AI age
The Hindu
At a recent roundtable in Delhi, hosted jointly by IBM and The Hindu Group, technology leaders discussed the shifts in thinking around cloud deployment costs, transitioning from a traditional view of finops (the financial sub-discipline of optimising cloud expenditure) to actually getting value out of deployments.
U.S. President Donald Trump to announce Federal Reserve chair nominee on January 30, amidst tensions with current chair Jerome Powell over interest rates.
Critical minerals are pivotal in energy transition, posing challenges for affordability and supply chains, warns CEA in Economic Survey.
The Economic Survey urges fiscal flexibility for the Centre while warning States about deteriorating financial conditions due to rising deficits.
Economic Survey highlights fodder shortages as key challenge for India's livestock and fisheries sectors, impacting growth and production costs.
The 2025-26 Economic Survey argues that prioritizing economic growth over immediate carbon cuts is essential for sustainable climate adaptation.
India's internet user base reaches 958 million, with 57% from rural areas, highlighting rapid digital adoption across the country.
The Economic Survey reveals a decline in agricultural growth to 3.5% in 2025-26, despite steady foodgrain production increases.
Economic Survey 2025-26 warns unconditional cash transfers risk state finances, impacting fiscal sustainability and medium-term growth.
Economic Survey 2025-26 advocates for tax rationalization on debt-assets to enhance investment in corporate bonds and savings.
Restrictions may also be levied on marketing of infant and toddler milk and beverages to tackle rising obesity
Commercial Vehicles major Tata Motors Ltd. (TML) for the third quarter ended December 31, 2025 reported a 48% fall in consolidated net profit to ₹705 crore as compared with ₹1,355 crore in the year ago period due to one-time impacts of Labour Code and de-merger.
India’s energy gap between supply and demand has dropped to nil by November 2025
India's pharma industry shifts to value-driven approaches, focusing on complex generics, innovation, and expanding medical device exports.